E. Mari

2.9k total citations
21 papers, 572 citations indexed

About

E. Mari is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, E. Mari has authored 21 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in E. Mari's work include Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Treatment and Pharmacology (3 papers). E. Mari is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Treatment and Pharmacology (3 papers). E. Mari collaborates with scholars based in Italy, United States and Egypt. E. Mari's co-authors include Maurizio Belfiglio, Stefano Cascinu, Roberto Labianca, Umberto Valentini, Sandro Barni, Valter Torri, Irene Floriani, Angelo Tinazzi, Alessandro Buda and Antonio Nicolucci and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

E. Mari

18 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Mari Italy 11 344 189 156 134 64 21 572
E. Testa Italy 12 304 0.9× 237 1.3× 76 0.5× 284 2.1× 95 1.5× 17 601
Eri Munekage Japan 12 159 0.5× 136 0.7× 65 0.4× 131 1.0× 37 0.6× 36 376
Soon-Tae Park South Korea 14 228 0.7× 123 0.7× 140 0.9× 175 1.3× 155 2.4× 33 569
Jun Arimoto Japan 15 373 1.1× 277 1.5× 151 1.0× 304 2.3× 208 3.3× 48 816
M Nardi Italy 9 148 0.4× 71 0.4× 63 0.4× 148 1.1× 38 0.6× 38 370
Kazuma Fujimoto Japan 15 563 1.6× 183 1.0× 340 2.2× 363 2.7× 101 1.6× 49 1.0k
Leo Taniguchi Japan 7 94 0.3× 154 0.8× 121 0.8× 171 1.3× 184 2.9× 11 428
Yuk T. Lee China 5 150 0.4× 139 0.7× 122 0.8× 213 1.6× 15 0.2× 8 533
Masato Kataoka Japan 12 200 0.6× 193 1.0× 58 0.4× 136 1.0× 68 1.1× 51 411
Goro Kajiyama Japan 14 172 0.5× 211 1.1× 27 0.2× 227 1.7× 149 2.3× 20 624

Countries citing papers authored by E. Mari

Since Specialization
Citations

This map shows the geographic impact of E. Mari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Mari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Mari more than expected).

Fields of papers citing papers by E. Mari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Mari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Mari. The network helps show where E. Mari may publish in the future.

Co-authorship network of co-authors of E. Mari

This figure shows the co-authorship network connecting the top 25 collaborators of E. Mari. A scholar is included among the top collaborators of E. Mari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Mari. E. Mari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Longo, Luca, Loredana Randazzo, Michela Bollati, et al.. (2025). Missense mutations in MMACHC protein from cblC disease affect its conformational stability and vitamin B12-binding activity: The example of R161Q mutation. Molecular Genetics and Metabolism. 145(3). 109150–109150.
2.
Mari, E., Silvia Vilasi, Paolo Moretti, et al.. (2024). Saponins Effect on Human Insulin Amyloid Aggregation. Biomolecules. 15(1). 40–40.
3.
Rossi, Antônio & E. Mari. (2022). EGFR-Mutant Non-small Cell Lung Cancer: State-of-the-Art and Future Perspectives. SHILAP Revista de lepidopterología. 2 indexed citations
4.
5.
6.
Alfieri, Roberta, Maricla Galetti, Roberta Andreoli, et al.. (2011). Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines. Molecular Cancer. 10(1). 143–143. 37 indexed citations
7.
Normanno, Nicola, Carmine Pinto, Gianluigi Taddei, et al.. (2011). EGFR FASTnet: The Italian network for epidermal growth factor receptors (EGFR) mutation analysis in non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 29(15_suppl). e18026–e18026. 1 indexed citations
8.
Santoro, Armando, Alessandro Comandone, Lorenza Rimassa, et al.. (2008). A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer. Annals of Oncology. 19(11). 1888–1893. 42 indexed citations
9.
Caponigro, Francesco, Amalia Milano, Raffaele Solla, et al.. (2008). A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. Anti-Cancer Drugs. 19(7). 739–744. 18 indexed citations
10.
11.
Mari, E., et al.. (2004). Dolor abdominal crónico en la infancia. Hacia la consulta de alta resolución en Atención Primaria. Pediatría Atención Primaria. 6(24). 597–604. 1 indexed citations
12.
Abdel-Fattah, Mohamed K., et al.. (2001). Current treatment modalities of breast-cancer patients in Alexandria, Egypt. The Breast. 10(6). 523–529. 7 indexed citations
13.
Mari, E., Irene Floriani, Angelo Tinazzi, et al.. (2000). Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials. Annals of Oncology. 11(7). 837–843. 273 indexed citations
14.
Scorpiglione, N., Maurizio Belfiglio, Fabrizio Carinci, et al.. (1999). The effectiveness, safety and epidemiology of the use of acarbose in the treatment of patients with type II diabetes mellitus. European Journal of Clinical Pharmacology. 55(4). 239–249. 20 indexed citations
15.
Valentini, Umberto, E. Mari, Maurizio Belfiglio, & Antonio Nicolucci. (1999). Is adjuvant tamoxifen used optimally in the treatment of breast cancer? Results of an Italian survey. Annals of Oncology. 10(7). 789–794. 3 indexed citations
16.
Nicolucci, Antonio, N. Scorpiglione, Maurizio Belfiglio, et al.. (1997). Patterns of Care of an Italian Diabetic Population. Diabetic Medicine. 14(2). 158–166. 25 indexed citations
17.
Scorpiglione, N., Mohamed El-Shazly, Mohamed K. Abdel-Fattah, et al.. (1996). Epidemiology and determinants of blood glucose self-monitoring in clinical practice. Diabetes Research and Clinical Practice. 34(2). 115–125. 17 indexed citations
18.
Nicolucci, Antonio, Fabrizio Carinci, D. Cavaliere, et al.. (1996). A Meta-analysis of Trials on Aldose Reductase Inhibitors in Diabetic Peripheral Neuropathy. Diabetic Medicine. 13(12). 1017–1026. 48 indexed citations
19.
Scorpiglione, N., Antonio Nicolucci, Roberto Grilli, et al.. (1994). [Geographic variability in the appropriateness of surgical treatment of breast carcinoma].. PubMed. 17. 44–50. 1 indexed citations
20.
Nicolucci, Antonio, F. Mainini, A. Penna, et al.. (1993). The influence of patient characteristics on the appropriateness of surgical treatment for breast cancer patients. Annals of Oncology. 4(2). 133–140. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Testa Breakdown of academic impact, for papers by Eri Munekage Breakdown of academic impact, for papers by Soon-Tae Park Breakdown of academic impact, for papers by Jun Arimoto Breakdown of academic impact, for papers by M Nardi Breakdown of academic impact, for papers by Kazuma Fujimoto Breakdown of academic impact, for papers by Leo Taniguchi Breakdown of academic impact, for papers by Yuk T. Lee Breakdown of academic impact, for papers by Masato Kataoka Breakdown of academic impact, for papers by Goro Kajiyama
Rankless by CCL
2026